Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.22 - $8.26 $207,234 - $327,922
-39,700 Reduced 40.35%
58,700 $478,000
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $6.4 Million - $10.9 Million
-1,049,700 Reduced 91.43%
98,400 $685,000
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $6.9 Million - $9.42 Million
888,200 Added 341.75%
1,148,100 $12.2 Million
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $9.4 Million - $11.8 Million
-1,439,300 Reduced 84.7%
259,900 $2.08 Million
Q3 2023

Nov 14, 2023

BUY
$7.69 - $9.71 $10.4 Million - $13.2 Million
1,356,400 Added 395.68%
1,699,200 $14 Million
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $435,292 - $669,680
-76,100 Reduced 18.17%
342,800 $2.74 Million
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $1.67 Million - $2.63 Million
266,500 Added 174.87%
418,900 $3.39 Million
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $15,225 - $19,825
-2,500 Reduced 1.61%
152,400 $957,000
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $1.05 Million - $2.1 Million
-228,500 Reduced 59.6%
154,900 $1.07 Million
Q2 2022

Aug 08, 2022

BUY
$7.06 - $23.63 $2.44 Million - $8.17 Million
345,800 Added 919.68%
383,400 $3.21 Million
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $1.55 Million - $2 Million
-71,800 Reduced 65.63%
37,600 $859,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $32,200 - $40,614
1,400 Added 1.3%
109,400 $3.02 Million
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $3.73 Million - $4.47 Million
-148,800 Reduced 57.94%
108,000 $3.01 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $5.38 Million - $6.42 Million
196,200 Added 323.76%
256,800 $7.53 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $1.12 Million - $1.81 Million
-52,600 Reduced 46.47%
60,600 $1.92 Million
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $1.44 Million - $1.99 Million
94,300 Added 498.94%
113,200 $2.36 Million
Q3 2020

Nov 16, 2020

SELL
$14.88 - $20.13 $970,176 - $1.31 Million
-65,200 Reduced 77.53%
18,900 $294,000
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $2.31 Million - $3.56 Million
-173,700 Reduced 67.38%
84,100 $1.54 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $4.56 Million - $10.6 Million
-351,600 Reduced 57.7%
257,800 $4 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $6.31 Million - $10.7 Million
334,200 Added 121.44%
609,400 $18.2 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $223,416 - $274,562
10,700 Added 4.05%
275,200 $6.01 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $9.98 Million - $12.9 Million
-486,200 Reduced 64.77%
264,500 $6.67 Million
Q1 2019

May 15, 2019

BUY
$20.23 - $26.29 $12.4 Million - $16.1 Million
611,400 Added 438.91%
750,700 $18.5 Million
Q4 2018

Feb 14, 2019

SELL
$17.64 - $28.32 $901,404 - $1.45 Million
-51,100 Reduced 26.84%
139,300 $2.57 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $3.93 Million - $4.89 Million
190,400 New
190,400 $4.89 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.